Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Strategic Diagnostics Turns To Profit In Q4

Strategic Diagnostics (SDIX: Quote), a biotechnology-based products provider, reported fourth-quarter net income of $1.7 million or $0.08 per share, compared to a net loss of $260,000 or $0.01 per share last year.

Results for the quarter included income from discontinued operations of $3.2 million

Revenues for the quarter declined to $5.5 million from $6.3 million last year.

Click here to receive FREE breaking news email alerts for Strategic Diagnostics Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks showed a significant recovery over the course of the trading day on Monday after coming under pressure in early trading. The markets eventually ended the session roughly flat following the mixed performance that was seen last week. House and Senate negotiators revealed Monday that they have reached an agreement on compromise legislation to reform the scandal-plagued Veterans Affairs Department. After reporting a sharp jump in U.S. pending home sales in the previous month, the National Association of Realtors released a report on Monday showing that pending home sales unexpectedly saw a notable pullback in the month of June.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.